Effects of ropivacaine on eicosanoid release from human granulocytes and endothelial cells in vitro

Inflammation Research

Volumn 46, Issue 10, 1997, Pages 398-403

  Martinsson, T ^a   Haegerstrand, A ^b   Dalsgaard, C J ^b  

^a ASTRAZENECA R AND D   (Sweden)

^b Research and Development at Scania Technical Centre   (Sweden)

Author keywords

Eicosanoids; Endothelial cells; Polymorphonuclear granulocytes; Ropivacaine; Ulcerative colitis

Indexed keywords

15 HYDROXYICOSATETRAENOIC ACID; 5 HYDROXYICOSATETRAENOIC ACID; 6 OXOPROSTAGLANDIN F1 ALPHA; ACETYLSALICYLIC ACID; ARACHIDONATE 5 LIPOXYGENASE; HYDROCORTISONE; ICOSANOID; IONOPHORE; LEUKOTRIENE B4; LIDOCAINE; MESALAZINE; ROPIVACAINE; THROMBIN; ZYMOSAN;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENCY; ENDOTHELIUM CELL; GRANULOCYTE; HUMAN; HUMAN CELL; IMMUNOASSAY; STATISTICAL ANALYSIS; ULCERATIVE COLITIS;

6-KETOPROSTAGLANDIN F1 ALPHA; AMIDES; ANESTHETICS, LOCAL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CELLS, CULTURED; EICOSANOIDS; ENDOTHELIUM, VASCULAR; GRANULOCYTES; HUMANS; HYDROCORTISONE; HYDROXYEICOSATETRAENOIC ACIDS; LEUKOTRIENE B4; LIDOCAINE; MESALAMINE; THROMBIN; ZYMOSAN;

EID: 0030709262     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000110050210     Document Type: Article

References (39)

1. 14C] arachidonic acid by human colonic mucosa. Gut 1983;24:1176-82.
2. 2 and prostacyclin production by cultured rectal mucosa in ulcerative colitis and its inhibition by steroids and sulfasalazine. Gastroenterology 1981;81:444-9.
3. 4 by colonic mucosa in inflammatory bowel disease. Gastroenterology 1984;86:453-60.
4. Rask-Madsen J. Eicosanoids and their role in the pathogenesis of diarrhoeal diseases. Clin Gastroenterol 1986;15:545-66.
5. 4 levels determined by equilibrium in vivo dialysis of rectum in relapsing ulcerative colitis. Gastroenterology 1986;91:837-44.
6. Nielsen OH, Bukhave K, Elmgreen J, Ahnfelt-Rønne I. Inhibition of 5-lipoxygenase pathway of arachidonic acid metabolism in human neutrophils by sulfasalazine and 5-aminosalicylic acid. Dig Dis Sci 1987;32:577-82.
7. Fantone JC, Ward PA. Polymorphonuclear leukocyte-mediated cell and tissue injury: Oxygen metabolites and their relations to human disease. Human Pathol 1985;16:973-8.
8. Samuelsson B, Dahlén S-E, Lindgren JÁ, Rouzer CA, Serhan CN. Leukotrienes and lipoxins: Structures, biosynthesis, and biological effects. Science 1987;237:1171-6.
9. Bertrán X, Mañe J, Fernández-Bañares F, Castellá E, Bartolí R, Ojanguren I, et al. Intracolonic administration of zileuton, a selective 5-lipoxygenase inhibitor, accelerates healing in a rat model of chronic colitis. Gut 1996;38:899-904.
10. Fretland DJ, Levin S, Tsai S, Djuric SW, Widomski DL, Zemaitis JM, et al. The effect of leukotriene B4 receptor antagonist. SC-41930, on acetic acid-induced colonie inflammation. Agents Actions 1989;27:395-7.
11. Wallace JL, Wallace K, MacNaughton WK, Morris GP, Beck PL. Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease. Gastroenterology 1989;96:29-36.
12. Wallace JL, Keenan CM. An orally active inhibitor of leukotriene synthesis accelerates healing in a rat model of colitis. Am J Physiol 1990;258:G527-34.
13. Spector AA, Gordon JA, Moore SA. Hydroxyeicosatetraenoic acid (HETEs). Prog Lipid Res 1988;27:271-323.
14. Lee SH, Soyoola E, Chanmugam P, Hart S, Sun W, Zhong H, et al. Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J Biol Chem 1992;267:25934-8.
15. Williams TJ. Interactions between prostaglandins, leukotrienes and other mediators of inflammation. Br Med Bull 1983;39:239-42.
16. Gould SR, Brash AR, Conolly ME, Lennard-Jones JE. Studies of prostaglandins and sulfasalazine in ulcerative colitis. Prostaglandins Med 1981;6:165-82.
17. Arlander E, Öst Ä, Stählberg D, Lötberg R. Ropivacaine gel in active distal ulcerative colitis and proctitis - a pharmacokinetic and exploratory clinical study. Aliment Pharmacol Ther 1996;10: 73-81.
18. Cederholm I, Briheim G, Rutberg H, Dahlgren C. Effects of five amino-amide local anaesthetic agents on human polymorphonuclear leukocytes measured by chemiluminesence. Acta Anaesthesiol Scand 1994;38:704-10.
19. Martinsson T, Oda T, Fernvik E, Roempke K, Dalsgaard C-J, Svensjö E. Ropivacaine inhibits leukocyte rolling, adhesion and CD11b/CD18 expression. J Pharmacol Exp Ther. In Press.
20. Cullen BF, Haschke RH. Local anesthetic inhibition of phagocytosis and metabolism of human leukocytes. Anesthesiology 1974;40:142-6.
21. Giddon DB, Lindhe J. In vivo quantitation of local anesthetic suppression of leukocyte adherence. Am J Pathol 1972;68:327-38.
22. Irita K, Fujita I, Takeshige K, Minakami S, Yoshitake J. Cinchocaine and amethocaine inhibit activation and activity of superoxide production in human neutrophils. Br J Anaesth 1986;58: 639-45.
23. MacGregor RR, Thorner RE, Wright DM. Lidocaine inhibits granulocyte adherence and prevents granulocyte delivery to inflammatory sites. Blood 1980;56:203-9.
24. Peck SL, Johnston RB Jr, Horwitz LD. Reduced neutrophil superoxide anion release after prolonged infusions of lidocaine. J Pharmacol Exp Ther 1985;235:418-22.
25. Rabinovitch M, DeStefano M. Cell to substrate adhesion and spreading: Inhibition by cationic anesthetics. J Cell Physiol 1975; 85:189-93.
26. 4 release and IL-1 secretion in vitro. Acta Anaesthesiol Scand 1993;37:159-65.
27. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 1973; 52:2745-56.
28. Sirois P, Borgeat P, Lauziere M, Dube L, Rubin P, Kesterson J. Effect of zileuton (A-64077) on the 5-lipoxygenase activity of human whole blood ex vivo. Agents Actions 1991;34:117-20.
29. 4-induced neutrophil migration across endothelium. J Clin Invest 1994;93: 499-508.
30. 4. Adv Exp Med Biol 1991;314:185-92.
31. Seibert K, Zhang Y, Leahy K, Hauser S, Masferrer J, Perkins W, et al. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc Natl Acad Sci USA 1994;91:12013-7.
32. Wallace JL, Whittle BJR, Boughton-Smith NK. Prostaglandin protection of rat colonic mucosa from damage induced by ethanol. Dig Dis Sci 1985;30:866-76.
33. Fedorak RN, Empey LR, MacArthur C, Jewell LD. Misoprostol provides a colonie mucosal protective effect during acetic acid-induced colitis in rats. Gastroenterology 1990;98:615-25.
34. Moncada S, Gryglewski R, Bunting S, Vane JR. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 1976;263:663-5.
35. Weissman G. Prostaglandins as modulators rather than mediators of inflammation. J Lipid Mediators 1993;6:275-86.
36. Stenson WF, Lobos E. Sulfazalazine inhibits the synthesis of chemotactic lipids by neutrophils. J Clin Invest 1982;69:494-7.
37. Hawkey CJ, Rampton DS. Prostaglandins and the gastrointestinal mucosa: Are they important in its function, disease, or treatment? Gastroenterology 1985;89:1162-88.
38. Roberts WG, Simon TJ, Berlin RG, Haggitt RC, Snyder ES, Stenson WF, et al. Leukotrienes in ulcerative colitis: Results of a multicenter trial of a leukotriene biosynthesis inhibitor. MK-591. Gastroenterology 1997;112:725-32.
39. Hawkey CJ, Dube LM, Rountree LV, Linnen PJ, Lancaster JF. A trial of zileuton versus mesalazine or placebo in the maintenance of remission of ulcerative colitis. The European Zileuton Study Group for Ulcerative Colitis. Gastroenterology 1997;112:718-24.